Financial Freedom LLC’s Pacira BioSciences PCRX Stock Holding History

Financial Freedom LLC’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21.7K	Buy	+867	New	+$22K	0.01%	222
2026 Q2	–	Sell	-867	Closed	-$19.6K	–	311
2026 Q1	$19.6K	Hold	867	–	–	0.01%	237
2025 Q4	$22.4K	Hold	867	–	–	0.01%	219
2025 Q3	$22.3K	Hold	867	–	–	0.01%	226
2025 Q2	$20.7K	Hold	867	–	–	0.01%	224
2025 Q1	$21.5K	Hold	867	–	–	0.01%	225
2024 Q4	$16.3K	Hold	867	–	–	0.01%	239
2024 Q3	$13K	Hold	867	–	–	0.01%	255
2024 Q2	$24.8K	Hold	867	–	–	0.01%	204
2024 Q1	$25.3K	Hold	867	–	–	0.02%	203
2023 Q4	$29.3K	Hold	867	–	–	0.02%	190
2023 Q3	$26.6K	Hold	867	–	–	0.02%	193
2023 Q2	$34.7K	Hold	867	–	–	0.02%	172
2023 Q1	$35.4K	Hold	867	–	–	0.03%	164
2022 Q4	$33.5K	Buy	+867	New	+$42.2K	0.02%	170

Other funds holding PCRX

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Financial Freedom LLC's PCRX Position: Q3 2026 in Review

Financial Freedom LLC opened a new position in Pacira BioSciences (PCRX) in Q3 2026: 867 shares worth $21.7K. The stake represents 0.01% of the portfolio and ranks #222 among its holdings. This is a return to the name: Financial Freedom LLC previously reported a position in PCRX as recently as Q1 2026.

Financial Freedom LLC first reported a position in PCRX in Q4 2022 and has held it in 15 quarters since. The position peaked at $35.4K in Q1 2023. 108 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

Financial Freedom LLC held 867 shares of Pacira BioSciences worth $21.7K as of Q3 2026.
Pacira BioSciences was a new Financial Freedom LLC position in Q3 2026.
Pacira BioSciences made up 0.01% of Financial Freedom LLC's portfolio in Q3 2026, its #222 holding.
Financial Freedom LLC first reported a position in Pacira BioSciences in Q4 2022 and has held it in 15 quarters since.
Financial Freedom LLC's Pacira BioSciences position peaked at $35.4K in Q1 2023.
108 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Financial Freedom LLC's 13F filing for Q3 2026, filed 6 Nov 2026.